Dynavax Technologies Q2 EPS $0.03 Beats $(0.09) Estimate, Sales $60.25M Beat $48.38M Estimate
Portfolio Pulse from Benzinga Newsdesk
Dynavax Technologies reported Q2 earnings of $0.03 per share, beating the analyst consensus estimate of $(0.09) by 133.33%. However, this is a 96.55% decrease from the same period last year. The company also reported quarterly sales of $60.25 million, beating the estimate of $48.38 million by 24.53%, but this is a 76.51% decrease from last year.
August 04, 2023 | 2:38 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Dynavax Technologies reported better than expected Q2 earnings and sales, but both figures significantly decreased compared to the same period last year.
While Dynavax Technologies beat Q2 earnings and sales estimates, the significant year-over-year decreases could potentially concern investors, leading to a neutral short-term impact on the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100